Gene · 3921
NIH grants1,143
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,143
Download this page as JSON| Grant | Title | RPSA papers | Newest fiscal year |
|---|---|---|---|
| P30DK072488 | Mid-Atlantic Nutrition Obesity Research Center | 1 | 2019 |
| P30GM114736 | Center for Pediatric Research (CPR) | 1 | 2019 |
| P50AG005133 | Alzheimer's Disease Research Center | 1 | 2019 |
| P50AG025688 | Emory Alzheimer's Disease Center | 1 | 2019 |
| P50AG047266 | University of Florida - Mt. Sinai Medical Center AD Research Center | 1 | 2019 |
| R00CA197762 | Investigating the role of the small GTPase RIT1 in lung adenocarcinoma | 1 | 2019 |
| R00CA204602 | A functional genomics approach to determine the mechanism of cellular response to new anti-cancer | 1 | 2019 |
| R00MH101367 | Neuroimaging genetics to study social cognitive deficits in ASD and schizophrenia | 1 | 2019 |
| R01AA022414 | Role of Munc13-1 as a presynaptic effector of ethanol action | 1 | 2019 |
| R01AG022381 | The VETSA Longitudinal MRI Twin Study of Aging | 1 | 2019 |
| R01AG033040 | MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults | 1 | 2019 |
| R01AG049607 | Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults | 1 | 2019 |
| R01AI120694 | Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages | 1 | 2019 |
| R01CA133085 | Role of IRF8 in Tumor Rejection and Suppression | 1 | 2019 |
| R01CA151898 | CRLF2 signaling in B-cell acute lymphoblastic leukemia | 1 | 2019 |
| R01CA178744 | Bayesian methods for complex, high-dimensional functional data in cancer research | 1 | 2019 |
| R01DA018673 | Psychometric and Genetic Assessments of Substance Use | 1 | 2019 |
| R01DK094777 | E. coli virulence gene expression during clinical UTIs in women | 1 | 2019 |
| R01DK104363 | DHA Reverses Gene Network Signatures of Fructose-induced Metabolic Syndrome | 1 | 2019 |
| R01DK109508 | Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/grants?page=24